Stay updated on CTP-692 Adjunctive Treatment in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the CTP-692 Adjunctive Treatment in Schizophrenia Clinical Trial page.

Latest updates to the CTP-692 Adjunctive Treatment in Schizophrenia Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange Detected- Page now includes a government funding notice and operating status guidance for NIH Clinical Center, plus a new MedlinePlus Genetics topic on Schizophrenia, and the revision version updated to v3.2.0. The previous v3.1.0 revision was removed.SummaryDifference4%

- Check25 days agoChange DetectedAppended version label (v3.1.0) and removal of multiple drug-safety related sections, indicating content consolidation and reorganization rather than new substantive content.SummaryDifference0.5%

- Check32 days agoChange DetectedRemoved a MedlinePlus Genetics topic on schizophrenia; no new topics were added. Overall, this reduces the page's coverage of genetics topics related to schizophrenia.SummaryDifference0.2%

- Check40 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%

- Check54 days agoChange DetectedThe web page has updated its facility name and location details, specifically changing from 'Saint Louis' to 'St Louis' while retaining the same geographical information. Additionally, it has introduced new content related to drug safety and counterfeit drugs.SummaryDifference1%

Stay in the know with updates to CTP-692 Adjunctive Treatment in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTP-692 Adjunctive Treatment in Schizophrenia Clinical Trial page.